The total number of adults living with either type 1 or type 2 diabetes in the world has surpassed 800 million - over four times the total number in 1990, according to findings from a global analysis ...
A team led by Mass General Brigham researchers demonstrated that inebilizumab reduced the risk of symptoms by 87% in patients with the rare affliction known as immunoglobulin G4–related disease (IgG4- ...
By Albert Allotey Accra, Nov. 15, GNA – Some Civil Society Organisations (CSOs) have called for the urgent need to for a comprehensive approach to managing diabetes, ...